fludarabine phosphate has been researched along with Cancer of Prostate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Alli, N; Balagopal, A; Bautista, M; Bhanumathy, KK; Dahiya, DK; Elhasasna, H; Freywald, A; Khan, R; Krishnan, A; Maranda, V; Patel, H; Vizeacoumar, FJ; Vizeacoumar, FS; Walke, P | 1 |
| Guo, J; Kong, Y; Li, L; Liu, P; Lv, N; Spencer, DM; Tang, J; Wang, X; Wei, W; Xiao, X; Xie, GX; Xie, X; Xie, Z; Yang, M | 1 |
| Both, GW; Dane, A; Jeyakumar, G; Martiniello-Wilks, R; Mortensen, E; Russell, PJ; Shaw, JM; Voeks, DJ; Wang, XY | 1 |
| Both, GW; Cameron, F; Cooke-Yarborough, C; Coulston, N; Ho, T; Lockett, TJ; Martiniello-Wilks, R; Moghaddam, M; Molloy, PL; Russell, PJ; Shaw, JM; Smith, IK; Wang, XY; Webster, LK | 1 |
| Both, GW; Dane, A; Martiniello-Wilks, R; Mortensen, E; Russell, PJ; Shaw, JM; Voeks, DJ; Wang, XY | 1 |
| Bennetts, E; Both, GW; Madden, V; Martiniello-Wilks, R; Russell, PJ; Smith, K; Voeks, D | 1 |
6 other study(ies) available for fludarabine phosphate and Cancer of Prostate
| Article | Year |
|---|---|
A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers.
Topics: Androgen Antagonists; Carcinoma, Neuroendocrine; Cell Line, Tumor; Drug Repositioning; Humans; Male; N-Myc Proto-Oncogene Protein; Prostatic Neoplasms; Reactive Oxygen Species; Vidarabine Phosphate | 2022 |
Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.
Topics: Animals; Arrestins; beta-Arrestins; Cell Death; Cell Line, Tumor; Escherichia coli; Gene Expression Regulation, Neoplastic; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Male; Metribolone; Mice; Promoter Regions, Genetic; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Rats; Vidarabine Phosphate | 2011 |
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.
Topics: Adenocarcinoma; Adenoviridae; Animals; Animals, Genetically Modified; Antimetabolites, Antineoplastic; Disease Models, Animal; Escherichia coli; Female; Genetic Therapy; Infusions, Parenteral; Male; Mice; Mice, Inbred C57BL; Prodrugs; Prostate; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Survival Analysis; Vidarabine Phosphate | 2004 |
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Replication; Drug Evaluation, Preclinical; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prodrugs; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Vidarabine Phosphate | 2004 |
Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Apoptosis; Cattle; Cell Proliferation; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Prodrugs; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Transduction, Genetic; Vidarabine Phosphate | 2004 |
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.
Topics: Adenine; Animals; Avian Sarcoma Viruses; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Male; Mastadenovirus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Prodrugs; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured; Vidarabine Phosphate | 2002 |